Wei Lin sold RVMD

June 17, 2024 · Form 4 insider transaction

Wei Lin sold 5,589 shares of Revolution Medicines, Inc. at $37.39 per share, a transaction worth $209.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
5,589
Price
$37.39
Total value
$209.0K
InsiderWei Lin
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 17, 2024
Filing dateJune 20, 2024
Shares owned after70,851
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.; This transaction was executed in multiple trades in prices ranging from $37.3867 to $37.3871, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 2,040 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024.; Includes 59,250 RSUs.

View the original Form 4 on SEC EDGAR